The Principals of NorthStar Capital Advisors have served some of the most successful and innovative companies within the life science industry (in the United States, Europe and India) in sectors including pharmaceuticals, biotechnology, clinical and research diagnostics, medical equipment and devices, laboratory services, health care information technology, generic and specialty drugs
In a challenging financial market environment, the Principals and Advisory Board of NorthStar Capital Advisors have succeeded in completing transactions in excess of $670 million (January, 2008 to December, 2009)